SMAD2 and myocardial infarction: Salvianolate reduces atrial fibrillation by inhibiting the TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in rats after myocardial infarction, thereby inhibiting atrial fibrosis (Qiu et al., 2018).